90 related articles for article (PubMed ID: 27329245)
1. Stimulation of cellular senescent processes, including secretory phenotypes and anti-oxidant responses, after androgen deprivation therapy in human prostate cancer.
Kawata H; Kamiakito T; Nakaya T; Komatsubara M; Komatsu K; Morita T; Nagao Y; Tanaka A
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):219-227. PubMed ID: 27329245
[TBL] [Abstract][Full Text] [Related]
2. Androgen depletion induces senescence in prostate cancer cells through down-regulation of Skp2.
Pernicová Z; Slabáková E; Kharaishvili G; Bouchal J; Král M; Kunická Z; Machala M; Kozubík A; Souček K
Neoplasia; 2011 Jun; 13(6):526-36. PubMed ID: 21677876
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin derivative (smsDX) targets cellular metabolism in prostate cancer cells after androgen deprivation therapy.
Yan L; Xing Z; Guo Z; Fang Z; Jiao W; Guo X; Xu Z; Fang Z; Liu Z
PLoS One; 2013; 8(2):e55790. PubMed ID: 23409045
[TBL] [Abstract][Full Text] [Related]
4. Effects of vortioxetine on hippocampal-related cognitive impairment induced in rats by androgen deprivation as a model of prostate cancer treatment.
Vaiana AM; Chen Y; Gelfond J; Johnson-Pais TL; Leach RJ; Ramamurthy C; Thompson IM; Morilak DA
Transl Psychiatry; 2023 Oct; 13(1):307. PubMed ID: 37788996
[TBL] [Abstract][Full Text] [Related]
5. Robust antigen-specific CD8 T cell tolerance to a model prostate cancer neoantigen.
Lopez-Bujanda ZA; Chaimowitz MG; Armstrong TD; Foote JB; Emens LA; Drake CG
Oncoimmunology; 2020 Sep; 9(1):1809926. PubMed ID: 33457094
[TBL] [Abstract][Full Text] [Related]
6. Lentiviral vector-mediated insertional mutagenesis screen identifies genes that influence androgen independent prostate cancer progression and predict clinical outcome.
Nalla AK; Williams TF; Collins CP; Rae DT; Trobridge GD
Mol Carcinog; 2016 Nov; 55(11):1761-1771. PubMed ID: 26512949
[TBL] [Abstract][Full Text] [Related]
7. A new perspective on prostate cancer treatment: the interplay between cellular senescence and treatment resistance.
Xu MY; Xia ZY; Sun JX; Liu CQ; An Y; Xu JZ; Zhang SH; Zhong XY; Zeng N; Ma SY; He HD; Wang SG; Xia QD
Front Immunol; 2024; 15():1395047. PubMed ID: 38694500
[TBL] [Abstract][Full Text] [Related]
8. Tea polyphenol-engineered hybrid cellular nanovesicles for cancer immunotherapy and androgen deprivation therapy.
Guo Y; Wu J; Chen L; Liu L; Bi T; Pan Y; Meng QF; Wang C; Rao L; Li Q
J Nanobiotechnology; 2024 Apr; 22(1):192. PubMed ID: 38637848
[TBL] [Abstract][Full Text] [Related]
9. Celastrol mediates CAV1 to attenuate pro-tumorigenic effects of senescent cells.
Zhang S; Zhu N; Shi YN; Zeng Q; Zhang CJ; Li HF; Qin L
Phytomedicine; 2024 Apr; 129():155614. PubMed ID: 38692078
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer.
Mori JO; Elhussin I; Brennen WN; Graham MK; Lotan TL; Yates CC; De Marzo AM; Denmeade SR; Yegnasubramanian S; Nelson WG; Denis GV; Platz EA; Meeker AK; Heaphy CM
Nat Rev Urol; 2024 May; 21(5):258-273. PubMed ID: 37907729
[TBL] [Abstract][Full Text] [Related]
11. Cellular senescence as a possible link between prostate diseases of the ageing male.
Fiard G; Stavrinides V; Chambers ES; Heavey S; Freeman A; Ball R; Akbar AN; Emberton M
Nat Rev Urol; 2021 Oct; 18(10):597-610. PubMed ID: 34294916
[TBL] [Abstract][Full Text] [Related]
12. Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen.
Drake CG; Doody AD; Mihalyo MA; Huang CT; Kelleher E; Ravi S; Hipkiss EL; Flies DB; Kennedy EP; Long M; McGary PW; Coryell L; Nelson WG; Pardoll DM; Adler AJ
Cancer Cell; 2005 Mar; 7(3):239-49. PubMed ID: 15766662
[TBL] [Abstract][Full Text] [Related]
13. KDM4 Orchestrates Epigenomic Remodeling of Senescent Cells and Potentiates the Senescence-Associated Secretory Phenotype.
Zhang B; Long Q; Wu S; Xu Q; Song S; Han L; Qian M; Ren X; Liu H; Jiang J; Guo J; Zhang X; Chang X; Fu Q; Lam EW; Campisi J; Kirkland JL; Sun Y
Nat Aging; 2021 May; 1(5):454-472. PubMed ID: 34263179
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells.
Colucci M; Zumerle S; Bressan S; Gianfanti F; Troiani M; Valdata A; D'Ambrosio M; Pasquini E; Varesi A; Cogo F; Mosole S; Dongilli C; Desbats MA; Contu L; Revankdar A; Chen J; Kalathur M; Perciato ML; Basilotta R; Endre L; Schauer S; Othman A; Guccini I; Saponaro M; Maraccani L; Bancaro N; Lai P; Liu L; Pernigoni N; Mele F; Merler S; Trotman LC; Guarda G; Calì B; Montopoli M; Alimonti A
Cancer Cell; 2024 Apr; 42(4):646-661.e9. PubMed ID: 38428412
[TBL] [Abstract][Full Text] [Related]
15. Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression.
Lazniewska J; Li KL; Johnson IRD; Sorvina A; Logan JM; Martini C; Moore C; Ung BS; Karageorgos L; Hickey SM; Prabhakaran S; Heatlie JK; Brooks RD; Huzzell C; Warnock NI; Ward MP; Mohammed B; Tewari P; Martin C; O'Toole S; Edgerton LB; Bates M; Moretti P; Pitson SM; Selemidis S; Butler LM; O'Leary JJ; Brooks DA
Sci Rep; 2023 Aug; 13(1):13489. PubMed ID: 37596305
[TBL] [Abstract][Full Text] [Related]
16. Resistance to Antiandrogens in Prostate Cancer: Is It Inevitable, Intrinsic or Induced?
Maitland NJ
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33477370
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional Heterogeneity of Cellular Senescence in Cancer.
Junaid M; Lee A; Kim J; Park TJ; Lim SB
Mol Cells; 2022 Sep; 45(9):610-619. PubMed ID: 35983702
[TBL] [Abstract][Full Text] [Related]
18. Retraction: Somatostatin Derivative (smsDX) Targets Cellular Metabolism in Prostate Cancer Cells after Androgen Deprivation Therapy.
PLOS ONE Editors
PLoS One; 2024; 19(2):e0299822. PubMed ID: 38408063
[No Abstract] [Full Text] [Related]
19. Correction: The key cellular senescence related molecule RRM2 regulates prostate cancer progression and resistance to docetaxel treatment.
Cheng B; Li L; Wu Y; Luo T; Tang C; Wang Q; Zhou Q; Wu J; Lai Y; Zhu D; Du T; Huang H
Cell Biosci; 2024 Feb; 14(1):17. PubMed ID: 38303092
[No Abstract] [Full Text] [Related]
20. Hydrogen Sulfide Induces Keap1 S-sulfhydration and Suppresses Diabetes-Accelerated Atherosclerosis via Nrf2 Activation.
Xie L; Gu Y; Wen M; Zhao S; Wang W; Ma Y; Meng G; Han Y; Wang Y; Liu G; Moore PK; Wang X; Wang H; Zhang Z; Yu Y; Ferro A; Huang Z; Ji Y
Diabetes; 2016 Oct; 65(10):3171-84. PubMed ID: 27335232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
